Portfolio (Quarterly)
Guide ↗
Stonepine Capital Management, LLC
· CIK 0001440771| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 50,010.0 | $556K | 0.22% | NEW | — | $11.11 | -0.1% |
| 22 | — | ONKURE THERAPEUTICS INC | — | 132,578.0 | $549K | 0.22% | NEW | — | $4.14 | — |
| 23 | XLO | XILIO THERAPEUTICS INC | Healthcare | 64,162.0 | $540K | 0.22% | NEW | — | $8.41 | -1.9% |
| 24 | CADL | CANDEL THERAPEUTICS INC | Healthcare | 102,500.0 | $502K | 0.20% | NEW | — | $4.90 | +62.2% |
| 25 | POCI | PRECISION OPTICS CORP INC MA | Healthcare | 100,000.0 | $439K | 0.18% | NEW | — | $4.39 | +13.2% |
| 26 | ESTA | ESTABLISHMENT LABS HLDGS INC | Healthcare | 6,000.0 | $341K | 0.14% | NEW | — | $56.78 | +27.9% |
| 27 | — | UPSTREAM BIO INC | — | 35,000.0 | $315K | 0.13% | NEW | — | $9.00 | — |
| 28 | — | OPUS GENETICS INC | — | 68,688.0 | $313K | 0.12% | NEW | — | $4.55 | — |
| 29 | ARVN | ARVINAS INC | Healthcare | 27,500.0 | $292K | 0.12% | NEW | — | $10.60 | -15.8% |
| 30 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 40,030.0 | $232K | 0.09% | NEW | — | $5.80 | +6.7% |
| 31 | NMRA | NEUMORA THERAPEUTICS INC. | Healthcare | 100,000.0 | $195K | 0.08% | NEW | — | $1.95 | -5.6% |
| 32 | — | SAB BIOTHERAPEUTICS INC | — | 50,000.0 | $192K | 0.08% | NEW | — | $3.83 | — |
| 33 | SIBN | SI BONE INC | Healthcare | 14,964.0 | $189K | 0.08% | NEW | — | $12.63 | +16.2% |
| 34 | KLRS | KALARIS THERAPEUTICS INC | Healthcare | 20,400.0 | $118K | 0.05% | NEW | — | $5.77 | -9.7% |
| 35 | — | BIOATLA INC | — | 65,387.0 | $11K | 0.00% | NEW | — | $0.16 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%